March 26, 2017 5:31 AM ET


Company Overview of UCB Pharma S.A.

Company Overview

UCB Pharma S.A. researches, develops, and commercializes pharmaceutical and biotechnology products. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. The company is based in Brussels, Belgium. UCB Pharma S.A. operates as a subsidiary of UCB S.A.

Allée de la Recherche, 60

Brussels,  1070



32 2 559 92 20


32 2 559 90 09

Key Executives for UCB Pharma S.A.

Vice President of Global Market Access and Pricing
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Amakem NV Europe
Aminolabs SA Europe
Apotheek Delestre NV Europe
Apotheek Moons NV Europe
Apotheek Philips NV Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact UCB Pharma S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at